Elliot Norry Adaptimmune Therapeutics PLC (ADAP) insider trading activity
Elliot Norry is Chief Medical Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 7,510 shares of ADAP, which is worth approximately $4,581. The most recent transaction as insider was on Jan 17, 2025, when has been sold 5,584 shares (American Depositary Shares representing Ordinary Shares) at a price of $0.58 per share, resulting in proceeds of $3,238. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
7.51K
61.0%
3M change
61.0%
12M change
Total Value Held
$4,581
Elliot Norry Transaction History
EN
Elliot Norry
Chief Medical Officer
Abingdon, X0